
Aptorum Group Limited APM
$ 0.89
-1.61%
Annual report 2025
added 04-11-2026
Aptorum Group Limited Total Inventories 2011-2026 | APM
Annual Total Inventories Aptorum Group Limited
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 39.1 K | 34.2 K | 30.6 K | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 39.1 K | 30.6 K | 34.7 K |
Quarterly Total Inventories Aptorum Group Limited
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 35.8 K | - | 32.8 K | - | 39.1 K | - | 34.3 K | - | 34.2 K | - | - | - | 30.6 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 39.1 K | 30.6 K | 34.5 K |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Alnylam Pharmaceuticals
ALNY
|
82.7 M | $ 309.66 | -3.27 % | $ 40.6 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
177 M | $ 22.88 | 4.91 % | $ 1.07 B | ||
|
BioXcel Therapeutics
BTAI
|
722 K | $ 1.15 | 7.48 % | $ 14 M | ||
|
Akebia Therapeutics
AKBA
|
15.6 M | $ 1.41 | 4.07 % | $ 363 M | ||
|
Aquestive Therapeutics
AQST
|
6.17 M | $ 4.32 | 1.41 % | $ 462 M | ||
|
Arcutis Biotherapeutics
ARQT
|
22.6 M | $ 24.53 | 1.41 % | $ 3.12 B | ||
|
BioDelivery Sciences International
BDSI
|
23.7 M | - | -4.8 % | $ 255 M | ||
|
Autolus Therapeutics plc
AUTL
|
33.2 M | $ 1.6 | -0.62 % | $ 426 M | ||
|
BeiGene, Ltd.
BGNE
|
608 M | - | 0.49 % | $ 251 B | ||
|
bluebird bio
BLUE
|
22.9 M | - | - | $ 546 M |